Kevin Charles Gorman
Director · 7 filings · Latest: Sep 11, 2026
NEUROCRINE BIOSCIENCES INC
Xencor Inc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
XNCR | Kevin Charles Gorman | Director | Jun 15, 2026 | Sale | $12.31 | 7,527 | $92.7K | 11,378 | |
XNCR | GORMAN KEVIN CHARLES | — | Jun 15, 2026 | Proposed Sale | $12.31 | 7,527 | $92.7K | — | |
NBIX | Kevin Charles Gorman | Director | May 19, 2026 | Sale | $154.33 | 245,088 | $37.8M | 511,293 | |
NBIX | Kevin Charles Gorman | Director | May 19, 2026 | Option Exercise | $43.24 | 205,088 | $8.9M | 756,381 | |
NBIX | KEVIN CHARLES GORMAN | — | May 19, 2026 | Proposed Sale | $157.21 | 245,088 | $38.5M | — | |
NBIX | Kevin Charles Gorman | Director | Feb 13, 2026 | Option Exercise | $0.00 | 10,981 | — | 524,850 | |
NBIX | Kevin Charles Gorman | Director | Jan 31, 2026 | Option Exercise | $0.00 | 5,142 | — | 519,738 | |
NBIX | KEVIN CHARLES GORMAN | — | Aug 7, 2025 | Proposed Sale | $128.43 | 106,322 | $13.7M | — | |
XNCR | GORMAN KEVIN CHARLES | — | Jun 16, 2025 | Proposed Sale | $9.22 | 3,173 | $29.3K | — | |
NBIX | KEVIN CHARLES GORMAN | — | May 27, 2025 | Proposed Sale | $120.18 | 9,613 | $1.2M | — | |
NBIX | KEVIN CHARLES GORMAN | — | Feb 13, 2025 | Proposed Sale | $117.18 | 3,012 | $352.9K | — | |
NBIX | Kevin Charles Gorman | — | Feb 13, 2025 | Proposed Sale | $117.18 | 2,832 | $331.9K | — | |
NBIX | KEVIN CHARLES GORMAN | — | Feb 10, 2025 | Proposed Sale | $122.62 | 2,274 | $278.8K | — | |
NBIX | KEVIN CHARLES GORMAN | — | Jan 31, 2025 | Proposed Sale | $153.29 | 2,707 | $415.0K | — | |
NBIX | KEVIN CHARLES GORMAN | — | Jan 27, 2025 | Proposed Sale | $148.73 | 146,105 | $21.7M | — | |
XNCR | GORMAN KEVIN CHARLES | — | Sep 27, 2024 | Proposed Sale | $20.68 | 2,654 | $54.9K | — |